These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9723828)

  • 1. Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration.
    Hussain FN; Ajjan RA; Moustafa M; Weir NW; Riley SA
    Br J Clin Pharmacol; 1998 Aug; 46(2):173-5. PubMed ID: 9723828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.
    Hussain FN; Ajjan RA; Riley SA
    Br J Clin Pharmacol; 2000 Apr; 49(4):323-30. PubMed ID: 10759687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
    Dmochowski R; Chen A; Sathyan G; MacDiarmid S; Gidwani S; Gupta S
    J Clin Pharmacol; 2005 Aug; 45(8):961-8. PubMed ID: 16027408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.
    Sandborn WJ; Hanauer SB
    Aliment Pharmacol Ther; 2003 Jan; 17(1):29-42. PubMed ID: 12492730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid Inhibitory Effect of a Combination of Omeprazole and Sodium Bicarbonate (CDFR0209) Compared With Delayed-Release Omeprazole 40 mg Alone in Healthy Adult Male Subjects.
    Kim KN; Yang SW; Kim H; Kwak SS; Kim YS; Cho DY
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):53-58. PubMed ID: 28111929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.
    Swift GL; Mills CM; Rhodes J; Evans BK; Bennett A; Tavares IA
    Aliment Pharmacol Ther; 1992 Apr; 6(2):259-66. PubMed ID: 1350926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers.
    Dixit RK; Chawla AB; Kumar N; Garg SK
    Methods Find Exp Clin Pharmacol; 2001; 23(1):37-9. PubMed ID: 11413862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers.
    Brunner M; Greinwald R; Kletter K; Kvaternik H; Corrado ME; Eichler HG; Müller M
    Aliment Pharmacol Ther; 2003 May; 17(9):1163-9. PubMed ID: 12752353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.
    Brunner M; Assandri R; Kletter K; Tschurlovits M; Corrado ME; Villa R; Eichler HG; Müller M
    Aliment Pharmacol Ther; 2003 Feb; 17(3):395-402. PubMed ID: 12562452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orally administered omeprazole on abomasal luminal pH in dairy calves fed milk replacer.
    Ahmed AF; Constable PD; Misk NA
    J Vet Med A Physiol Pathol Clin Med; 2005 Jun; 52(5):238-43. PubMed ID: 15943608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters.
    Hussain FN; Ajjan RA; Kapur K; Moustafa M; Riley SA
    Aliment Pharmacol Ther; 2001 Jan; 15(1):53-62. PubMed ID: 11136278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.
    Brunner M; Lackner E; Exler PS; Fluiter HC; Kletter K; Tschurlovits M; Dudczak R; Eichler HG; Müller M
    Aliment Pharmacol Ther; 2006 Jan; 23(1):137-44. PubMed ID: 16393291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.
    Washington C; Hou E; Hughes N; Berner B
    Am J Health Syst Pharm; 2006 Apr; 63(7):653-6. PubMed ID: 16554289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.
    Horn JR; Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():20-4. PubMed ID: 16303033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
    Winston A; Back D; Fletcher C; Robinson L; Unsworth J; Tolowinska I; Schutz M; Pozniak AL; Gazzard B; Boffito M
    AIDS; 2006 Jun; 20(10):1401-6. PubMed ID: 16791014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.